+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
Fusion Proteins - Global Strategic Business Report - Product Thumbnail Image

Fusion Proteins - Global Strategic Business Report

  • Report
  • November 2024
  • 88 Pages
  • Global
From
From
From
From
From
Targeted Oncology Therapeutics: Breast Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Breast Cancers

  • Report
  • October 2021
  • 68 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 380 Pages
  • Global
From
Urinary Tract Cancer Global Market Report 2024 - Product Thumbnail Image

Urinary Tract Cancer Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Urothelial Carcinoma Treatment Global Market Report 2024 - Product Thumbnail Image

Urothelial Carcinoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
From
Loading Indicator